GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Other Gross PPE

NeoImmuneTech (XKRX:950220) Other Gross PPE : ₩7,228.35 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Other Gross PPE?

NeoImmuneTech's Other Gross PPE for the quarter that ended in Mar. 2024 was ₩7,228.35 Mil.

NeoImmuneTech's quarterly Other Gross PPE declined from Sep. 2023 (₩7,173.17 Mil) to Dec. 2023 (₩7,141.10 Mil) but then increased from Dec. 2023 (₩7,141.10 Mil) to Mar. 2024 (₩7,228.35 Mil).

NeoImmuneTech's annual Other Gross PPE declined from Dec. 2021 (₩7,040.37 Mil) to Dec. 2022 (₩6,945.47 Mil) but then increased from Dec. 2022 (₩6,945.47 Mil) to Dec. 2023 (₩7,141.10 Mil).


NeoImmuneTech Other Gross PPE Historical Data

The historical data trend for NeoImmuneTech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Other Gross PPE Chart

NeoImmuneTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
2,925.06 3,310.85 7,040.37 6,945.47 7,141.10

NeoImmuneTech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,356.00 7,198.25 7,173.17 7,141.10 7,228.35

NeoImmuneTech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


NeoImmuneTech (XKRX:950220) Business Description

Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines